No events were found.
Remember to bookmark this page.

Contact Us

News

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

Send an eCard to Friends or Family Members in Support of Crohn's and Colitis Canada

Send an eCard to Friends or Family Members in Support of Crohn's and Colitis Canada

Today, September 30, Marks the Second National Day for Truth and Reconciliation in Canada

Today, September 30, Marks the Second National Day for Truth and Reconciliation in Canada

 7 8 9 10 11 12 13 14 15 16